The Paris system in reporting urinary cytology and correlating with follow up histopathological evaluation, in tertiary care hospital
Keywords:
Paris System for Reporting Urinary Cytology (PSRUC), atypical, cytology, urineAbstract
Introduction: Away from diagnostic importance, urinary tract endoscopy is a painful, expensive and time consuming procedure. Now a time, The Paris System for Reporting Urinary Cytology (TPSRUC) has lead to prime changes in the perspective of assessment in urine cytology and pattern of reporting. Our focus in this study was to evaluate the impact of implementing The Paris system in reporting urinary cytology and correlating with follow up histopathological evaluation. Patients & Method: It is a Retrospective study of 6 months duration, from January 2021 to June 2021 using 156 urine samples in Cytology section, Department of pathology at Dhiraj hospital Waghodia. All freshly collected urine specimens were centrifuge, prepared as Thin slides fixed with methanol and stained with Hematoxylin & eosin (H&E) and Papanicolaou stain then evaluated under light microscopy. Results: In total, 156 cytology specimens the sample was composed of 90 (58%) men and 66 (42%) women (the ratio of men to women was 1.4:1).
Downloads
References
Andersson K.-E., Arner A. Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology. Physiol. Rev. 2004;84:935– 986. doi: 10.1152/physrev.00038.2003. [PubMed] [CrossRef] [Google Scholar]
Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DFI, et al. The Paris system for reporting urinary cytology: the quest to develop a standardized terminology. Acta Cytol. 2016;60(3):185–97.
Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. [PubMed] [CrossRef] [Google Scholar]
Cowan ML, Rosenthal DL, VandenBussche CJ. Improved risk stratification for patients with highgrade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology. Cancer Cytopathol. 2017; 125: 427– 434. Wiley Online Library | CAS | PubMed | Web of Science® | Google Scholar
Cowan ML, VandenBussche CJ. The Paris system for reporting urinary cytology: early review of the literature reveals successes and rare shortcomings. J Am Soc Cytopathol. 2018 Jul–Aug;7(4):185–94.
Crossref | PubMed | Web of Science® | Google Scholar
Dev HS, Poo S, Armitage J, Wiseman O, Shah N, Al-Hayek S. Investigating upper urinary tract urothelial carcinomas: A single-centre 10-year experience. World J Urol. 2017;35:131–8. [PMC free article] [PubMed] [Google Scholar]
Dorothy L. Rosenthal, Eva M. Wojcik, Daniel F.I. Kurtycz, The Paris System for Reporting Urinary Cytology. Springer cham: XIX, 159
Emily Chan, Balassanian. Improved diagnostic precision of urine cytology by implementation of The Paris System and the use of cell blocks. Cancer Cytopathology / Volume 126, Issue 9 / p. 809-816
Ferlay J., Ervik M., Lam F., Colombet M., Mery L., Piñeros M., Znaor A., Soerjomataram I., Bray F. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; Lyon, France: 2018. [(accessed on 10 January 2020)]. Available online: https://gco.iarc.fr/ [Google Scholar]
Hassan M, Solanki S, Kassouf W, et al. Impact of implementing the Paris System for Reporting Urine Cytology in the performance of urine cytology: a correlative study of 124 cases. Am J Clin Pathol. 2016; 146: 384– 390. Crossref | PubMed | Web of Science® | Google Scholar
Hassan M, Solanki S, Kassouf W, Kanber Y, Caglar D, Auger M, et al. Impact of implementing the Paris system for reporting urine cytology in the performance of urine cytology: a correlative study of 124 cases. Am J Clin Pathol. 2016 Sep;146(3):384–90.
Hassan M, Solanki S, Kassouf W, Kanber Y, Caglar D, Auger M, et al. Impact of implementing the Paris system for reporting urine cytology in the performance of urine cytology: A Correlative study of 124 cases. Am J Clin Pathol. 2016;146:384–90. [PubMed] [Google Scholar]
Jones PA, Droller MJ. Pathway of development and progression in bladder cancer: new correlations between clinical observations and molecular mechanisms. Semin Urol 1993;11:177–92. [PubMed] [Google Scholar]
Lokeshwar VB, Habuchi T, Grossman HB, Murphy WM, Hautmann SH, Hemstreet GP, et al. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology. 2005;66:35–63. [PubMed] [Google Scholar]
Malviya K, Fernandes G, Naik L, et al. Utility of the Paris System in reporting urine cytology. Acta Cytol. 2017;61:145-152.
Malviya K, Fernandes G, Naik L, Kothari K, Agnihotri M. Utility of The Paris System in reporting urine cytology. Acta Cytol. 2017; 61: 145– 152.
Malviya K, Fernandes G, Naik L, Kothari K, Agnihotri M. Utility of the Paris system in reporting urinary cytology. Acta Cytol. 2017;61:145–52. [PubMed] [Google Scholar]
Miki Y, Neat M, Chandra A. Application of the Paris System to atypical urine cytology samples: correlation with histology and UroVysion FISH. Cytopathology. 2017; 28: 88– 95.
Roy M, Jain D, Kaushal S, et al. An institutional experience with the Paris System: a paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology. Cytopathology. 2017;28:509-515.
Sharda et al. A Quest for Accuracy: Evaluation of The Paris System in Diagnosis of Urothelial Carcinomas, J Cytol. 2019 Jul-Sep; 36(3): 169–173
Somaye Zare, MD, Leili Mirsadraei, MD, et. Al , A Single Institutional Experience With the Paris System for Reporting Urinary Cytology Correlation of Cytology and Histology in 194 Cases. Am J Clin Pathol August 2018;150:162-16
Suh J, Go H, Sung C, et al. Modication of the Paris System for urinary tract washing specimens using diagnostic cytological features. Cytopathology. 2017; 28: 516– 523.
Wiley Online Library | CAS | PubMed | Web of Science® | Google Scholar
Wiley Online Library | CAS | PubMed | Web of Science® | Google Scholar
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
